Literature DB >> 20466923

The population dynamics and control of tuberculosis.

Christopher Dye1, Brian G Williams.   

Abstract

More than 36 million patients have been successfully treated via the World Health Organization's strategy for tuberculosis (TB) control since 1995. Despite predictions of a decline in global incidence, the number of new cases continues to grow, approaching 10 million in 2010. Here we review the changing relationship between the causative agent, Mycobacterium tuberculosis, and its human host and examine a range of factors that could explain the persistence of TB. Although there are ways to reduce susceptibility to infection and disease, and a high-efficacy vaccine would boost TB prevention, early diagnosis and drug treatment to interrupt transmission remain the top priorities for control. Whatever the technology used, success depends critically on the social, institutional, and epidemiological context in which it is applied.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20466923     DOI: 10.1126/science.1185449

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  237 in total

1.  Importance of confirming data on the in vivo efficacy of novel antibacterial drug regimens against various strains of Mycobacterium tuberculosis.

Authors:  Mary A De Groote; Veronica Gruppo; Lisa K Woolhiser; Ian M Orme; Janet C Gilliland; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

Review 2.  The challenge of new drug discovery for tuberculosis.

Authors:  Anil Koul; Eric Arnoult; Nacer Lounis; Jerome Guillemont; Koen Andries
Journal:  Nature       Date:  2011-01-27       Impact factor: 49.962

3.  Vaccination of guinea pigs using mce operon mutants of Mycobacterium tuberculosis.

Authors:  Andrés Obregón-Henao; Crystal Shanley; María Verónica Bianco; Angel A Cataldi; Randall J Basaraba; Ian M Orme; Fabiana Bigi
Journal:  Vaccine       Date:  2011-04-22       Impact factor: 3.641

4.  Molecular dynamics of Mycobacterium tuberculosis KasA: implications for inhibitor and substrate binding and consequences for drug design.

Authors:  Benjamin Schaefer; Caroline Kisker; Christoph A Sotriffer
Journal:  J Comput Aided Mol Des       Date:  2011-11-11       Impact factor: 3.686

5.  The renaissance of continuous culture in the post-genomics age.

Authors:  Alan T Bull
Journal:  J Ind Microbiol Biotechnol       Date:  2010-09-11       Impact factor: 3.346

6.  Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.

Authors:  Stephan Schwander; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-11-12       Impact factor: 21.405

Review 7.  TB control: challenges and opportunities for India.

Authors:  Madhukar Pai; Amrita Daftary; Srinath Satyanarayana
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-03       Impact factor: 2.184

8.  Mycobacterium bovis Persistence in Two Different Captive Wild Animal Populations in Germany: a Longitudinal Molecular Epidemiological Study Revealing Pathogen Transmission by Whole-Genome Sequencing.

Authors:  Thomas A Kohl; Christian Utpatel; Stefan Niemann; Irmgard Moser
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

9.  Host cell-induced components of the sulfate assimilation pathway are major protective antigens of Mycobacterium tuberculosis.

Authors:  Rachel Pinto; Lisa Leotta; Erin R Shanahan; Nicholas P West; Thomas S Leyh; Warwick Britton; James A Triccas
Journal:  J Infect Dis       Date:  2012-12-07       Impact factor: 5.226

10.  Polyphosphate deficiency in Mycobacterium tuberculosis is associated with enhanced drug susceptibility and impaired growth in guinea pigs.

Authors:  Ramandeep Singh; Mamta Singh; Garima Arora; Santosh Kumar; Prabhakar Tiwari; Saqib Kidwai
Journal:  J Bacteriol       Date:  2013-04-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.